Feasibility and efficacy of neoadjuvant cabozantinib and nivolumab in patients with borderline resectable or locally advanced hepatocellular carcinoma (HCC).

被引：16

作者：

Yarchoan, Mark ^{[1
]}

Zhu, Qingfeng ^{[2
]}

Durham, Jennifer N. ^{[3
]}

Gross, Nicole ^{[1
]}

Charmsaz, Soren ^{[1
]}

Leatherman, James M. ^{[4
]}

Zhang, Shu ^{[1
]}

Popovic, Aleksandra ^{[5
]}

Weiss, Matthew John ^{[6
]}

Philosophe, Benjamin ^{[7
]}

Burkhart, Richard A. ^{[8
]}

Burns, William ^{[9
]}

Wilt, Brad ^{[7
]}

Sugar, Elizabeth ^{[7
]}

Fertig, Elana J. ^{[10
]}

Laheru, Dan ^{[11
]}

Anders, Robert A. ^{[2
]}

Jaffee, Elizabeth M. ^{[10
]}

Ho, Won Jin ^{[1
]}

机构：

[1] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[2] Johns Hopkins, Bloomberg Kimmel Inst Canc Immunotherapy, Dept Pathol, Baltimore, MD USA

[3] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[4] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[5] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[6] Northwell Hlth Canc Inst, Manhasset, NY USA

[7] Johns Hopkins, Baltimore, MD USA

[8] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA

[9] Univ Michigan, Ann Arbor, MI 48109 USA

[10] Johns Hopkins Univ, Baltimore, MD USA

[11] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 03期

关键词：

D O I：

10.1200/JCO.2021.39.3_suppl.335

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

335

引用

页数：3

共 50 条

[1] Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity
Won Jin Ho
Qingfeng Zhu
Jennifer Durham
Aleksandra Popovic
Stephanie Xavier
James Leatherman
Aditya Mohan
Guanglan Mo
Shu Zhang
Nicole Gross
Soren Charmsaz
Dongxia Lin
Derek Quong
Brad Wilt
Ihab R. Kamel
Matthew Weiss
Benjamin Philosophe
Richard Burkhart
William R. Burns
Chris Shubert
Aslam Ejaz
Jin He
Atul Deshpande
Ludmila Danilova
Genevieve Stein-O’Brien
Elizabeth A. Sugar
Daniel A. Laheru
Robert A. Anders
Elana J. Fertig
Elizabeth M. Jaffee
Mark Yarchoan
[J]. Nature Cancer, 2021, 2 : 891 - 903
[2] Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity
Ho, Won Jin
Zhu, Qingfeng
Durham, Jennifer
Popovic, Aleksandra
Xavier, Stephanie
Leatherman, James
Mohan, Aditya
Mo, Guanglan
Zhang, Shu
Gross, Nicole
Charmsaz, Soren
Lin, Dongxia
Quong, Derek
Wilt, Brad
Kamel, Ihab R.
Weiss, Matthew
Philosophe, Benjamin
Burkhart, Richard
Burns, William R.
Shubert, Chris
Ejaz, Aslam
He, Jin
Deshpande, Atul
Danilova, Ludmila
Stein-O'Brien, Genevieve
Sugar, Elizabeth A.
Laheru, Daniel A.
Anders, Robert A.
Fertig, Elana J.
Jaffee, Elizabeth M.
Yarchoan, Mark
[J]. NATURE CANCER, 2021, 2 (09) : 891 - +
[3] Feasibility of neoadjuvant cabozantinib plus nivolumab followed by definitive resection for patients with locally advanced hepatocellular carcinoma: A Phase Ib trial (NCT03299946)
Popovic, Aleksandra
Sugar, Elizabeth
Ferguson, Anna
Wilt, Bradley
Durham, Jennifer N.
Kamel, Ihab R.
Kim, Amy
Philosophe, Benjamin
Anders, Robert A.
Jaffee, Elizabeth M.
Laheru, Daniel
Weiss, Matthew J.
Yarchoan, Mark
[J]. CANCER RESEARCH, 2019, 79 (13)
[4] Neoadjuvant Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer
Kovtun, K.
Moser, J. A.
Callery, M.
Kent, T.
Tseng, J.
Miksad, R.
Bullock, A.
Schlechter, B.
Mahadevan, A.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E198 - E198
[5] Multimodal integrative genomics and pathology analyses in neoadjuvant nivolumab treatment for borderline resectable HCC
Cheung, Tan-to
Ho, Daniel
Lyu, Shirley
Zhang, Qingyang
Tsui, Yu
Yu, Tiffany
Sze, Karen
Lee, Joyce
Lau, Vince
Chu, Yin-Lun
Tsang, Simon
She, Wong
Leung, Roland
Yau, Thomas
Ng, Irene Oi-Lin
[J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S51 - S52
[6] Neoadjuvant chemoradiotherapy to convert borderline-resectable, locally-advanced esophageal carcinoma to resectable disease.
Horne, Zachary D.
Sun, Weijing
Gibson, Michael K.
Pennathur, Arjun
Luketich, James D.
Greenberger, Joel S.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[7] Efficacy and safety of nivolumab in asian patients with advanced hepatocellular carcinoma (HCC): Subanalysis of the CheckMate 040 Study
Choo, S. P.
Yau, T.
Hsu, C.
Kang, Y-K.
Hou, M-M.
Yeo, W.
Numata, K.
Chopra, A.
Baakili, A.
Dela Cruz, C.
Zhao, H.
Kudo, M.
[J]. ANNALS OF ONCOLOGY, 2017, 28
[8] Sequential neoadjuvant chemotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma
Paluri, Ravi Kumar
McCormack, Michael Joseph, Jr.
Neal, Austin
Moore, Stacie
Shen, Perry
Clark, Clancy
Ogburn, Olivia
Dressler, Emily Van Meter
Deep, Gagan
Greissinger, April
Mcilwain, Laura
Yacoub, George
Sirkisoon, Sherona
Lima, Caio Max Sao Pedro Rocha
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[9] Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
Roberto Alva-Ruiz
Lavanya Yohanathan
Jennifer A. Yonkus
Amro M. Abdelrahman
Lindsey A. Gregory
Thorvadur R. Halfdanarson
Amit Mahipal
Robert R. McWilliams
Wen Wee Ma
Christopher L. Hallemeier
Rondell P. Graham
Travis E. Grotz
Rory L. Smoot
Sean P. Cleary
David M. Nagorney
Michael L. Kendrick
Mark J. Truty
[J]. Annals of Surgical Oncology, 2022, 29 : 1579 - 1591
[10] Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
Alva-Ruiz, Roberto
Yohanathan, Lavanya
Yonkus, Jennifer A.
Abdelrahman, Amro M.
Gregory, Lindsey A.
Halfdanarson, Thorvadur R.
Mahipal, Amit
McWilliams, Robert R.
Ma, Wen Wee
Hallemeier, Christopher L.
Graham, Rondell P.
Grotz, Travis E.
Smoot, Rory L.
Cleary, Sean P.
Nagorney, David M.
Kendrick, Michael L.
Truty, Mark J.
[J]. ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (03) : 1579 - 1591

← 1 2 3 4 5 →